Biotech | August 01, 2025
Fermenta receives CEP by EDQM for Vitadee 100 SD
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
Doxorubicin Hydrochloride Liposome Injection is indicated for the treatment of Ovarian Cancer, AIDS-Related Kaposi's Sarcoma, and Multiple Myeloma
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
The Board of Directors of the company recommends a final dividend of Rs. 42 per equity share for the 12 months period ended March 31, 2025
The Q1 2025 also witnessed a successful launch of Allegra D
The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home
The unique soap-fusion of Gondhoraj lime and neem provides a refreshing skin-friendly experience
The stethoscope features high acoustic sensitivity and active noise cancellation, minimizing ambient interference to improve auscultation clarity, particularly in noisy hospital settings
Subcutaneous pembrolizumab administered every six weeks with a median injection time of two minutes, in combination with chemotherapy, shows consistent results across reported efficacy and safety endpoints compared to IV KEYTRUDA in combination with chemotherapy
EBITDA rose to Rs. 14.8 crore, marking a 16.5% y-o-y increase, while net profit surged to Rs. 6.4 crore
Subscribe To Our Newsletter & Stay Updated
